Cargando…

Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()

OBJECTIVE: The exceptional health situation related to the SARS-Cov2 coronavirus pandemic (COVID-19) required a deep and very quickly adaptation of management practices in gynecological cancer. The main objective is to estimate the proportion of patients with treatment modifications. METHOD: This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamblin, G., Golfier, F., Peron, J., Moret, S., Chene, G., Nohuz, E., Lebon, M., Dubernard, G., Cortet, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526595/
https://www.ncbi.nlm.nih.gov/pubmed/33010487
http://dx.doi.org/10.1016/j.gofs.2020.09.011
_version_ 1783588906070966272
author Lamblin, G.
Golfier, F.
Peron, J.
Moret, S.
Chene, G.
Nohuz, E.
Lebon, M.
Dubernard, G.
Cortet, M.
author_facet Lamblin, G.
Golfier, F.
Peron, J.
Moret, S.
Chene, G.
Nohuz, E.
Lebon, M.
Dubernard, G.
Cortet, M.
author_sort Lamblin, G.
collection PubMed
description OBJECTIVE: The exceptional health situation related to the SARS-Cov2 coronavirus pandemic (COVID-19) required a deep and very quickly adaptation of management practices in gynecological cancer. The main objective is to estimate the proportion of patients with treatment modifications. METHOD: This is a multicenter prospective study conducted in 3 university gynecological cancer departments (HCLyon, France) during the period of confinement (March 16 to May 11, 2020). All patients with non-metastatic breast cancer or gynecological cancer were included. The planned treatment, postponement, delay and organizational modifications (RCP, teleconsultations) were studied. RESULTS: Two hundred and five consecutive patients were included, average age 60.5 ± 1.0. 7 patients (3.4%) had SARS-Cov-2 infection, 2 patients died. One hundred and twenty-two patients (59.5%) had a treatment maintained, 72 patients (35.1%) postponed, 11 patients (5.4%) cancelled. Of the 115 (56.1%) planned surgeries, 40 (34.8%) postponed, 7 cancelled (6.1%). 9 patients (7.8%) had a surgical modification. Of the 59 (28.8%) radiotherapy treatments scheduled, 24 (40.7%) postponed and 2 (3.4%) cancelled. Of the 56 (27.3%) chemotherapy treatment planned, 8 (14.3%) postponed and 2 (3.6%) cancelled. One hundred and forty-five patients (70.7%) have been discussed in multidisciplinary meeting. One hundred and fifty-eight patients (77%) had a teleconsultation system. CONCLUSION: Our study assessed the impact of the COVID-19 pandemic on therapeutic management of patients with gynecological cancer during the period of confinement. This will probably improve our management of an eventual epidemic rebound or future health crisis.
format Online
Article
Text
id pubmed-7526595
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-75265952020-10-01 Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques() Lamblin, G. Golfier, F. Peron, J. Moret, S. Chene, G. Nohuz, E. Lebon, M. Dubernard, G. Cortet, M. Gynecol Obstet Fertil Senol Article Original OBJECTIVE: The exceptional health situation related to the SARS-Cov2 coronavirus pandemic (COVID-19) required a deep and very quickly adaptation of management practices in gynecological cancer. The main objective is to estimate the proportion of patients with treatment modifications. METHOD: This is a multicenter prospective study conducted in 3 university gynecological cancer departments (HCLyon, France) during the period of confinement (March 16 to May 11, 2020). All patients with non-metastatic breast cancer or gynecological cancer were included. The planned treatment, postponement, delay and organizational modifications (RCP, teleconsultations) were studied. RESULTS: Two hundred and five consecutive patients were included, average age 60.5 ± 1.0. 7 patients (3.4%) had SARS-Cov-2 infection, 2 patients died. One hundred and twenty-two patients (59.5%) had a treatment maintained, 72 patients (35.1%) postponed, 11 patients (5.4%) cancelled. Of the 115 (56.1%) planned surgeries, 40 (34.8%) postponed, 7 cancelled (6.1%). 9 patients (7.8%) had a surgical modification. Of the 59 (28.8%) radiotherapy treatments scheduled, 24 (40.7%) postponed and 2 (3.4%) cancelled. Of the 56 (27.3%) chemotherapy treatment planned, 8 (14.3%) postponed and 2 (3.6%) cancelled. One hundred and forty-five patients (70.7%) have been discussed in multidisciplinary meeting. One hundred and fifty-eight patients (77%) had a teleconsultation system. CONCLUSION: Our study assessed the impact of the COVID-19 pandemic on therapeutic management of patients with gynecological cancer during the period of confinement. This will probably improve our management of an eventual epidemic rebound or future health crisis. Elsevier Masson SAS. 2020-11 2020-09-30 /pmc/articles/PMC7526595/ /pubmed/33010487 http://dx.doi.org/10.1016/j.gofs.2020.09.011 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article Original
Lamblin, G.
Golfier, F.
Peron, J.
Moret, S.
Chene, G.
Nohuz, E.
Lebon, M.
Dubernard, G.
Cortet, M.
Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
title Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
title_full Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
title_fullStr Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
title_full_unstemmed Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
title_short Impact de la pandémie de Covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
title_sort impact de la pandémie de covid-19 sur les modifications thérapeutiques des patientes atteintes de cancers gynécologiques()
topic Article Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526595/
https://www.ncbi.nlm.nih.gov/pubmed/33010487
http://dx.doi.org/10.1016/j.gofs.2020.09.011
work_keys_str_mv AT lambling impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT golfierf impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT peronj impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT morets impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT cheneg impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT nohuze impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT lebonm impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT dubernardg impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques
AT cortetm impactdelapandemiedecovid19surlesmodificationstherapeutiquesdespatientesatteintesdecancersgynecologiques